Panama Medical Device Registration: The DNDM Law 90 Compliance Guide

A comprehensive regulatory guide to medical device registration and licensing in Panama under DNDM, Law 90, Executive Decree 490, and Law 419.

Panama has long served as a vital commercial gateway for the Americas. Driven by major logistics hubs like the Colón Free Zone and the Panamá Pacífico special economic area, the country represents a key entry point for multinational medical device manufacturers targeting Central America and the broader SICA (Sistema de la Integración Centroamericana) region. However, navigating Panama's medical device regulatory landscape requires a clear understanding of its distinct legal structures.

For many years, medical devices were regulated under generic health product legislation alongside pharmaceuticals. This created significant administrative bottlenecks. In 2017, Panama enacted a major legislative reform, establishing a dedicated regulatory authority and compliance pathway specifically designed for medical technologies.

This comprehensive guide details the regulatory pathway for medical devices in Panama. We dissect the legal framework established by Law 90 of 2017 and Executive Decree 490 of 2019, explain the Class A to D risk classification system, detail the dossier requirements for Sanitary Registration (Registro Sanitario), examine the expedited pathways introduced by Law 419 of 2024, outline the requirements for local establishment licensing, and provide a step-by-step roadmap for foreign manufacturers targeting this market.

Scenario Question: We are expanding our medical device sales to Panama. How is the regulatory pathway structured under the Ministry of Health's Dirección Nacional de Dispositivos Médicos (DNDM), and what are the specific steps, timelines, and costs to achieve compliance under Law 90 and Executive Decree 490?

Direct Answer: Under Panama's Law 90 of 2017, all medical devices and related products must obtain a Sanitary Registration (Registro Sanitario) from the Dirección Nacional de Dispositivos Médicos (DNDM), an independent directorate under the Ministry of Health (MINSA), before they can be imported, distributed, or commercialized. Devices are classified into Class A, B, C, and D based on risk (conforming to GHTF/IMDRF rules). Sanitary registrations are valid for 10 years and require a local Authorized Representative (AR) and Spanish labeling/IFU. Standard registration timelines are 4 to 12 months, but under Law 419 (2024), devices already approved in high-standard countries (like US FDA or CE mark) can qualify for an expedited 10-business-day pathway. Official government registration fees range from $50 to $5,000 depending on the risk class, and local distributors must hold a valid 3-year operating license.

1. The Legal Framework: Law 90, Law 92, and Executive Decree 490

To understand the current compliance landscape, manufacturers must look at the legislative evolution of Panama's medical device oversight. Historically, medical devices were regulated under Law 1 of 10 January 2001 (Ley de Medicamentos), which was managed by the Dirección Nacional de Farmacia y Drogas (DNFD). Because Law 1 was designed primarily for pharmaceuticals, medical device reviews suffered from inappropriate evidentiary standards, long backlogs, and a lack of technical expertise tailored to physical equipment and software.

To address these inefficiencies, the Panamanian government enacted Law 90 of 26 December 2017, which established a dedicated regulatory framework specifically for medical devices, separate from drugs. Law 90 created the Dirección Nacional de Dispositivos Médicos (DNDM) under the Ministry of Health (MINSA) to act as the sole administrative authority responsible for the registration, licensing, and post-market surveillance of all medical devices in the country.

Shortly thereafter, Law 92 of 2019 introduced key amendments to Law 90, primarily establishing transitional measures to prevent market disruption. These amendments allowed public healthcare institutions to continue procuring devices using temporary "Technical Criteria Certificates" while the DNDM finalized the operational structure for issuing full Sanitary Registries.

The definitive regulations implementing Law 90 were established by Executive Decree No. 490 of 4 October 2019. This decree provides the detailed operational guidelines that govern DNDM activities today, including:

The formal administrative structure and powers of the DNDM.
The adoption of a risk-based classification system for medical devices.
The technical documentation requirements for obtaining a Sanitary Registration.
The requirements for obtaining an Operating License (Licencia de Operación) for local establishments involved in manufacture, import, distribution, or storage.
The post-market vigilance and enforcement mechanisms.

By establishing the DNDM and enacting Decree 490, Panama aligned its national regulatory requirements with international standards, distinguishing device-specific compliance from the older pharmaceutical-centric models. This system is similar to other regional regulatory structures, such as Costa Rica's registration process and El Salvador's DNM registry analysis.

2. Regulatory Split: DNDM (Devices) vs. DNFD (Pharmaceuticals)

A common point of confusion for foreign manufacturers is the operational overlap between the DNDM and the DNFD. While both directorates sit under MINSA, their scopes are strictly separated:

Dirección Nacional de Farmacia y Drogas (DNFD): Governs pharmaceuticals, active pharmaceutical ingredients (APIs), cosmetics, food supplements, and chemical health products. The DNFD operates under Law 1 of 2001 and Executive Decree 115 of 2022.
Dirección Nacional de Dispositivos Médicos (DNDM): Governs medical devices, in vitro diagnostics (IVDs), medical gases, and related software. The DNDM operates under Law 90 of 2017 and Executive Decree 490 of 2019.

This distinction is critical for market entry. If an establishment or product is incorrectly classified under the DNFD rather than the DNDM, manufacturers will face significant compliance errors. For example, a local distributor must hold an operating license issued specifically by the DNDM for medical devices, rather than a generic pharmaceutical distributor license issued by the DNFD.

Furthermore, the DNDM relies on a specialized technical committee known as the National Interinstitutional Technical Committee (CTNI). The CTNI is composed of representatives from MINSA, the Social Security Fund (Caja de Seguro Social - CSS), and university biomedical departments. The CTNI is responsible for evaluating technical specifications and clinical safety profiles, particularly for public hospital procurement, ensuring that devices are evaluated by engineers and clinical specialists rather than pharmacologists.

3. Medical Device Risk Classification in Panama

Article 15 of Executive Decree 490 of 2019 establishes a risk-based classification system for medical devices that aligns with the Global Harmonization Task Force (GHTF) and International Medical Device Regulators Forum (IMDRF) standards. Devices are categorized into four classes based on their intended use, duration of contact with the human body, invasiveness, and systemic effects:

Class A (Low Risk)

These are non-invasive devices or devices that do not contact the patient directly, posing minimal risk to human health.

Examples: Manual wheelchairs, surgical drapes, bandages, non-invasive examination gloves, manual stethoscopes.
DNDM Oversight: Simplified registration process; technical documentation focuses on manufacturing quality standards (e.g., ISO 13485) and basic safety declarations.

Class B (Low-Moderate Risk)

These devices are moderately invasive or contact the patient's body for short durations, but do not pose severe risks if malfunction occurs.

Examples: Hypodermic needles, suction equipment, contact lenses, diagnostic ultrasound probes, surgical sutures.
DNDM Oversight: Requires detailed technical descriptions, sterilization validation data, and quality system certifications.

Class C (Moderate-High Risk)

These are invasive devices intended for long-term use, or devices that deliver energy or interface directly with central organ systems.

Examples: Mechanical ventilators, orthopedic implants, infusion pumps, hemodialysis equipment, anesthesia machines.
DNDM Oversight: Requires a full technical dossier, including clinical evaluation summaries, risk analysis reports (conforming to ISO 14971) and usability studies.

Class D (High Risk)

These are critical devices designed to monitor, support, or correct central circulatory or nervous system functions, or devices containing active substances or animal tissues.

Examples: Pacemakers, coronary stents, implantable defibrillators, artificial heart valves, neurological catheters.
DNDM Oversight: Highest level of technical review; requires complete clinical trial reports, biocompatibility testing data (ISO 10993), design dossiers, and post-market clinical follow-up plans.

The table below summarizes the four risk classes, standard DNDM review timelines, government registration fees, and document depth:

Device Class	Risk Level	DNDM Review Timeline (Standard)	Government Registration Fee Range (USD)	Technical Dossier Depth
Class A	Low	3 to 5 Months	$50 – $150	Basic (QMS, CFS, labeling)
Class B	Low-Moderate	4 to 8 Months	$150 – $500	Moderate (QMS, CFS, sterilization, design specs)
Class C	Moderate-High	6 to 10 Months	$500 – $2,000	Deep (QMS, CFS, risk analysis, clinical summaries)
Class D	High	8 to 12 Months	$2,000 – $5,000	Comprehensive (Full clinical trials, design history file)

Note: Timelines represent standard administrative processing times at the DNDM. Delays may occur if the DNDM issues technical deficiency letters (requiring additional data). Actual project costs will vary when including local representation, translation, and legalization fees.

4. Dossier Requirements for DNDM Sanitary Registration

To obtain a Sanitary Registration (Registro Sanitario), foreign manufacturers cannot submit their dossiers directly to the DNDM. They must work through a local Authorized Representative (AR) in Panama. The AR must be a legally registered Panamanian company holding a valid DNDM Operating License. The AR submits the application and acts as the legal liaison between the manufacturer and the Ministry of Health.

The technical dossier submitted to the DNDM must be compiled in Spanish and contain the following essential documents:

Legal and Quality Credentials

Power of Attorney (POA): A legal document executed by the foreign manufacturer appointing the local AR to manage the sanitary registration. This document must be signed by a corporate officer, notarized, and legalized via Apostille (or authenticated by the Panamanian consulate in the country of origin).
Certificate of Free Sale (CFS): Issued by the national regulatory authority of the manufacturer's home country (e.g., US FDA, an EU competent authority, or Health Canada). The CFS must state that the device is legally commercialized in the country of origin, and it must be apostilled or consularized.
Quality Management System (QMS) Certificate: The manufacturer must demonstrate compliance with international quality standards. The DNDM accepts ISO 13485 certification, FDA Quality System Regulation (21 CFR Part 820) audit reports, or Medical Device Single Audit Program (MDSAP) certificates.

Technical and Safety Documentation

Device Description and Technical Specifications: Detailed information regarding the design, materials, components, and operating mechanisms of the device. For active devices, electrical safety and electromagnetic compatibility (EMC) reports must be included.
Risk Management File: A comprehensive risk assessment demonstrating compliance with ISO 14971 standards, detailing identified hazards, risk mitigation steps, and proof of acceptable residual risk.
Biocompatibility and Sterilization Studies: For patient-contacting devices, biocompatibility test reports conforming to the ISO 10993 series are mandatory. If the device is sold sterile, sterilization validation reports (e.g., ethylene oxide, gamma radiation) must be provided.
Clinical Evaluation Report (CER): For Class C and D devices, a CER summarizing published clinical literature, clinical trial results, and post-market safety data is required to prove the clinical utility and safety profile of the technology.

Labeling and Instructions

Spanish Labeling and Instructions for Use (IFU): Article 32 of Executive Decree 490 requires that all labeling, external packaging, and IFUs be in Spanish. The DNDM will reject dossiers if the user-facing material is only in English, unless the device is strictly limited to specialized clinical settings and the DNDM grants a technical exception. The labeling must display:
- The trade name and descriptive name of the device.
- The manufacturer's name and country of origin.
- The local importer/distributor details.
- The Sanitary Registration number (to be added post-approval).
- Lot number or serial number.
- Expiry date (where applicable) and storage conditions.

5. Establishment Licensing (Licencia de Operación)

A Sanitary Registration only authorizes a specific medical device to be commercialized in Panama; it does not grant the right to physically import or store the product. To manage the physical handling of medical devices, local entities must secure an Operating License (Licencia de Operación) from the DNDM.

Scope of Licensing

Under Law 90, any establishment involved in the following activities must hold a valid DNDM Operating License:

Importers: Companies that purchase devices from foreign manufacturers and bring them into Panamanian customs.
Distributors: Companies that sell devices to public hospitals, private clinics, or retail pharmacies.
Storage Warehouses: Third-party logistics (3PL) providers that store medical devices.
Manufacturers: Local facilities that assemble or manufacture medical devices.
Exporters: Companies that re-export devices from Panamanian free zones.

Key Compliance Requirements

To secure and maintain an Operating License, the local establishment must comply with strict operational standards:

Technical Director (Regente Técnico): Every licensed establishment must employ a qualified Technical Director to oversee operations. Unlike drug distributors, which require a licensed pharmacist, a medical device establishment can appoint a Biomedical Engineer, Clinical Engineer, or Pharmacist registered with the Panamanian council. The Technical Director is legally responsible for quality control, batch traceability, temperature monitoring, and reporting adverse events to the DNDM.
Good Storage and Distribution Practices (BPAD): Establishments must undergo a physical audit by MINSA inspectors to verify compliance with BPAD standards. The facility must demonstrate:
- Temperature and humidity controls appropriate for the stored devices.
- Strict separation of approved, quarantined, and rejected stocks.
- Traceability procedures capable of executing a product recall within 24 hours.
- Documented pest control and cleaning protocols.
Validity: DNDM Operating Licenses are issued for a multi-year term (commonly cited as 3 years under Resolution 600 of 2018) and must be renewed before expiration, subject to a follow-up MINSA inspection. The exact term and renewal window are set by DNDM implementing resolutions, so confirm the current requirement with your Authorized Representative at filing.

6. Expedited Pathways and Public Procurement: Law 419 of 2024

One of the most significant regulatory developments in Panama is the enactment of Law 419 of 1 February 2024, which regulates the public procurement of medicines, medical devices, and other health products. Law 419 was passed to address chronic supply shortages in the public healthcare system and introduce modern purchasing mechanisms.

The Law 419 Expedited Pathway

To accelerate the availability of advanced medical technologies, Law 419 establishes an expedited registration pathway for medical devices that are already approved by regulatory agencies in countries recognized for their high standards.

If a manufacturer has obtained market clearance or approval from one of the following recognized authorities, they can leverage this fast-track route:

United States: Food and Drug Administration (FDA)
European Union: European Medicines Agency (EMA) or CE certificates from EU Notified Bodies
Canada: Health Canada
Switzerland: Swissmedic
Japan: Ministry of Health, Labour and Welfare (MHLW) / PMDA
Australia: Therapeutic Goods Administration (TGA)

Under this pathway, the DNDM limits its review primarily to verifying the validity of the foreign approval (via CFS and QMS credentials) and reviewing the Spanish labeling/IFU. The standard technical dossier review is bypassed. According to recent MINSA guidelines, registrations under this expedited route can be completed in as little as 10 business days, compared to the 4 to 12 months required for the standard review process.

Public Sector Bidding (MINSA & CSS)

The public sector is the largest buyer of medical devices in Panama, representing approximately 70% to 75% of the total market value. Public procurement is managed by two main entities:

Ministerio de Salud (MINSA): Operates public hospitals and regional health centers.
Caja de Seguro Social (CSS): The social security health system, which operates its own network of clinics and hospitals.

To bid on public tenders issued by MINSA or the CSS, a medical device must have a valid Sanitary Registration. In addition, the bidder must secure a Technical Verification Certificate (Certificado de Criterio Técnico).

The Technical Verification Certificate (governed by Executive Decree 468 of 2007 and Resolution 600 of 2018) is issued for a multi-year term (commonly cited as 5 years) by the National Interinstitutional Technical Committee (CTNI) after checking that the device meets the specific technical and clinical criteria defined in the public bidding documents. Law 419 allows public institutions to conduct joint bidding processes and establish long-term supply contracts, making technical compliance and registry maintenance vital for long-term commercial success.

For manufacturers coordinating these registration and bidding steps with their wider regional market-access plans, integrating these timelines with your broader reimbursement strategy is critical.

7. Step-by-Step Commercialization Roadmap

For foreign medical device manufacturers targeting the Panamanian market, navigating the registration process involves a clear sequence of steps:

graph TD
    A[Step 1: Appoint Local AR] --> B[Step 2: Collect & Legalize Dossier]
    B --> C[Step 3: Translate & Adapt Spanish Labeling]
    C --> D[Step 4: AR Submits to DNDM Portal]
    D --> E{DNDM Technical Review}
    E -- Standard Route: 4-12 Mo --> F[Sanitary Registry Issued]
    E -- Law 419 Route: 10 Days --> F
    F --> G[Step 5: Verify Importer Operating License]
    G --> H[Step 6: Importation & BPAD Traceability]

Step 1: Partner Selection and AR Appointment

Select a reliable local distributor or professional regulatory consultant to act as your Authorized Representative (AR). Execute the Power of Attorney (POA) and have it notarized and apostilled in your home country. Ensure that your chosen partner holds an active DNDM Operating License.

Step 2: Dossier Preparation and Legalization

Request the Certificate of Free Sale (CFS) from your national regulator (e.g., FDA or EU competent authority) and have it apostilled. Compile your QMS certificates (ISO 13485 or MDSAP), risk management file, sterilization validation reports, and clinical evaluation summaries.

Step 3: Spanish Translation and Labeling Adaptation

Translate all user-facing materials, including device labels, outer box packaging, and the instructions for use (IFU), into Spanish. Ensure that the translation accurately reflects the DNDM labeling requirements, including the placement of importer details.

Step 4: Submission and DNDM Review

The local AR uploads the legalized documents and technical dossier to the DNDM electronic portal and pays the official government registration fees. The DNDM reviews the submission:

If utilizing the Law 419 pathway: The DNDM verifies the foreign reference clearance and Spanish labeling, aiming to issue the registry within 10 business days.
If utilizing the standard pathway: The DNDM conducts a full technical and clinical review. If the reviewers identify gaps, they will issue a deficiency letter. The manufacturer typically has 30 working days to respond with the requested data.

Step 5: Sanitary Registration Issuance

Once the DNDM is satisfied with the technical and legal compliance of the submission, it issues the Sanitary Registration certificate. The registration is valid for 10 years. The registration number must be printed on the device packaging or labels before commercial sale.

Step 6: Importer License Validation and Customs Clearance

Before shipping the first commercial batch, ensure that the importing entity holds a valid DNDM Operating License for warehousing and distribution. During customs clearance, the importer must present the Sanitary Registration certificate and commercial invoices. The Technical Director must verify batch numbers and perform quality inspections upon arrival in accordance with Good Storage and Distribution Practices (BPAD).

FAQ Section

How are medical devices classified in Panama?

Panama classifies medical devices based on risk into four categories: Class A (low risk), Class B (low-moderate risk), Class C (moderate-high risk), and Class D (high risk). This system conforms to GHTF/IMDRF rules, evaluating the device's invasiveness, contact duration, and active energy delivery.

How long is a Panama Sanitary Registration valid?

A Sanitary Registration (Registro Sanitario) issued by the Dirección Nacional de Dispositivos Médicos (DNDM) is valid for 10 years. Renewals must be submitted through your local Authorized Representative before expiration to avoid import disruptions.

What is the expedited registration pathway under Law 419?

Under Law 419 of 2024, medical devices that have already obtained marketing approval from recognized regulatory bodies (such as the U.S. FDA, Health Canada, EU Notified Bodies, Swissmedic, PMDA Japan, or TGA Australia) qualify for an expedited DNDM review. This fast-track process bypasses standard technical evaluations and can be completed in approximately 10 business days.

Does a medical device manufacturer need a local representative in Panama?

Yes. Foreign manufacturers must appoint a local Authorized Representative (AR) legally established in Panama. The AR must hold a valid DNDM Operating License and acts as the official liaison for registrations, customs imports, and post-market vigilance.

Can a foreign manufacturer hold the Sanitary Registration directly?

The Sanitary Registration certificate is issued to the local Authorized Representative on behalf of the foreign manufacturer. To maintain control over commercial assets, manufacturers should execute clear contractual agreements with their AR, specifying that the registration is the property of the manufacturer and can be transferred to another licensed representative if necessary.

References

Ministerio de Salud de Panamá (MINSA). Dirección Nacional de Dispositivos Médicos (DNDM) Portal. minsa.gob.pa.
Asamblea Nacional de Panamá. Ley 90 de 26 de diciembre de 2017 que regula los dispositivos médicos y productos afines en la República de Panamá. Gaceta Oficial Digital No. 28434-A. gacetaoficial.gob.pa.
Ministerio de Salud (MINSA). Decreto Ejecutivo No. 490 de 4 de octubre de 2019 que reglamenta la Ley 90 de 26 de diciembre de 2017. Gaceta Oficial Digital No. 28876-B. gacetaoficial.gob.pa.
Asamblea Nacional de Panamá. Ley 419 de 1 de febrero de 2024 que regula los medicamentos y otros productos para la salud humana y la adquisición pública de estos. Gaceta Oficial Digital No. 29962-B. gacetaoficial.gob.pa.
Asamblea Nacional de Panamá. Ley 92 de 12 de septiembre de 2019 que modifica la Ley 90 de 2017. Gaceta Oficial Digital No. 28860-A. gacetaoficial.gob.pa.
International Bar Association (IBA). Medical Device Regulation in Latin America: A Comparative Overview. ibanet.org.
Dentons. New Regulatory Framework for Medical Devices in Panama. dentons.com.